Decades after individual states began to allow the use of cannabis for medicinal purposes, licensed dispensaries still can’t ...
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 23, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential ...
On the surface there's nothing unusual about this relative performance. The GLD has by far the lowest risk exposure and is ...
The Harbor SMID Cap Core ETF returned 5.67% in Q3 2025, focusing on high-quality businesses with durable earnings. Explore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results